Omada Health raises margin targets; Barclays lifts price target
Omada Health raised long-term targets, including gross margin to 80% and adjusted EBITDA margin to 30%. Barclays maintained an Overweight rating and lifted its price target to $27.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
OMDA raises long-term targets to 80% gross margin
OMDA outlined strategy-driven long-term targets, including 80% gross margin and 30% EBITDA margin.